Supriya Lifescience Limited (SUPRIYA) — Capital Reinvestment Ratio

Latest as of September 2025: 0.76x

Supriya Lifescience Limited (SUPRIYA) has a Capital Reinvestment Ratio of 0.76x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs555.65 Million) in capital expenditures (Rs422.49 Million). See SUPRIYA equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.76x
Capex / Operating Cash Flow

Operating Cash Flow

Rs555.65 Million
INR

Capital Expenditures

Rs422.49 Million
INR

Data as of

Sep 2025
Most recent filing

Supriya Lifescience Limited Capital Reinvestment Ratio (2018–2025)

This chart tracks Supriya Lifescience Limited's Capital Reinvestment Ratio across 8 annual periods. Check Supriya Lifescience Limited investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Supriya Lifescience Limited (2018–2025)

Year-by-year Capital Reinvestment Ratio for Supriya Lifescience Limited from 2018 to 2025. For live market cap and broader valuation context, see Supriya Lifescience Limited (SUPRIYA) market capitalisation.

Year Reinvestment Ratio Operating CF (INR) Capital Expenditures YoY Change
2025 0.94x Rs1.73 Billion Rs1.62 Billion ▼ -26.8%
2024 1.29x Rs1.13 Billion Rs1.46 Billion ▼ -21.5%
2023 1.64x Rs661.87 Million Rs1.08 Billion ▲ +33.4%
2022 1.23x Rs488.01 Million Rs599.04 Million ▲ +103.4%
2021 0.60x Rs799.30 Million Rs482.41 Million ▲ +185.6%
2020 0.21x Rs1.16 Billion Rs245.25 Million ▲ +48.1%
2019 0.14x Rs486.72 Million Rs69.45 Million ▼ -49.5%
2018 0.28x Rs174.52 Million Rs49.30 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow